Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.42 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.38 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.38 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.38 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.38 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.38 |
| ▸ | GHSR | Q92847 | 3/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.37 |
| ▸ | CDK2 | P24941 | 2/20 | 0.37 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31188431 | 0.92 | SLC15A2 (0.42) | SLC15A2GHSROPRK1 | |
| SCHEMBL30834755 | 0.92 | SLC15A2 (0.44) | SLC15A2GHSRCCNA2CDK2CCNA1 | |
| SCHEMBL29940001 | 0.92 | SLC15A2 (0.49) | SLC15A2PSMB1PSMB8PSMB9PSMB5 | |
| SCHEMBL31453805 | 0.91 | SLC15A2 (0.46) | SLC15A2PSMB1PSMB8PSMB9PSMB5 | |
| SCHEMBL31453794 | 0.91 | SLC15A2 (0.46) | SLC15A2PSMB1PSMB8PSMB9PSMB5 | |
| SCHEMBL30645282 | 0.91 | SLC15A2 (0.46) | SLC15A2PSMB1PSMB8PSMB9PSMB5 | |
| SCHEMBL24616668 | 0.90 | SLC15A2 (0.38) | SLC15A2GHSRCCNA2CDK2CCNA1 | |
| SCHEMBL24616667 | 0.90 | SLC15A2 (0.38) | SLC15A2GHSRCCNA2CDK2CCNA1 | |
| SCHEMBL29531670 | 0.90 | OPRK1 (0.44) | SLC15A2OPRK1CCNA2CDK2CCNA1 | |
| SCHEMBL29398799 | 0.90 | CCNA2 (0.44) | SLC15A2GHSROPRK1CCNA2CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116585283-B | Lansoprazole enteric capsule and preparation method thereof | 桂林华信制药有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-116585283-A | Lansoprazole enteric capsule and preparation method thereof | 桂林华信制药有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-116585283-B | Lansoprazole enteric capsule and preparation method thereof | 桂林华信制药有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-116585283-B | Lansoprazole enteric capsule and preparation method thereof | 桂林华信制药有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-116585283-A | Lansoprazole enteric capsule and preparation method thereof | 桂林华信制药有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-116585283-A | Lansoprazole enteric capsule and preparation method thereof | 桂林华信制药有限公司 | 2023-08-15 | — | — | CN | disclosed |